Latest news
Acadia Pharmaceuticals CFO Mark C. Schneyer disposes of 25,141 common shares worth $730,047.52 - BitgetBitget · Fri, 07 Aug 2026 14:00:51 GMTIs ACADIA Pharmaceuticals (ACAD) Outperforming Other Medical Stocks This Year? - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:40:02 GMTACADIA PHARMACEUTICALS INC SEC Filing (Aug 5, 2026) - Stock TitanStock Titan · Wed, 05 Aug 2026 20:50:18 GMTACADIA Pharmaceuticals Inc. Stock 12‑Month Price Target Raised to $33.25, Implies 22% Upside - TradingViewTradingView · Wed, 05 Aug 2026 17:20:05 GMTACADIA Pharmaceuticals Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ACAD) 2026-08-05 - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 13:45:20 GMTACADIA Pharmaceuticals Inc (ACAD) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 05:06:08 GMTIs Acadia Pharmaceuticals (ACAD) Fairly Valued After Q2 Earnings - GuruFocusGuruFocus · Tue, 04 Aug 2026 23:56:19 GMTACADIA Pharmaceuticals Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 22:03:55 GMT